Nitric oxide therapy is an effective, FDA-approved method to treat conditions like hypoxic respiratory failure with pulmonary hypertension in newborns ages 34 weeks and older. Share on Pinterest Jill ...
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an ...
Vietnamese and international experts are seeking advancing early prevention solutions against the burden of pediatric ...
Very severe medically attended RSV-associated LRTI was defined as infection for which hospitalization and supplemental oxygen or intravenous fluids were warranted. Data are from the intention-to-treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results